EMD-51509

Single-particle
4.23 Å
EMD-51509 Deposition: 09/09/2024
Map released: 12/02/2025
Last modified: 02/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-51509

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

PbuCas13b-crRNA complex, open conformation

EMD-51509

Single-particle
4.23 Å
EMD-51509 Deposition: 09/09/2024
Map released: 12/02/2025
Last modified: 02/04/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Segatella buccae, synthetic construct
Sample: Cas13b (cr)RNA complex

Deposition Authors: Schmelz S, Lukat P, Blankenfeldt W
AcrVIB1 inhibits CRISPR-Cas13b immunity by promoting unproductive crRNA binding accessible to RNase attack.
Wandera KG, Schmelz S, Migur A, Kibe A, Lukat P, Achmedov T, Caliskan N, Blankenfeldt W, Beisel CL
(2025) Mol Cell , 85 , 1162 - 1175.e7
PUBMED: 39965569
DOI: doi:10.1016/j.molcel.2025.01.020
ISSN: 1097-2765
ASTM: MOCEFL
Grant Support: